Literature DB >> 6664662

Toxicity of antineoplastic drugs in vitrectomy infusion fluids.

A Barrada, G A Peyman, D Greenberg, T Stelmack, R Fiscella.   

Abstract

Twelve antineoplastic drugs were evaluated for their toxicity when used in vitrectomy infusion fluid. These drugs may have implications in the prevention of cellular proliferation inside the eye.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6664662

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN： 0022-023X


  7 in total

Review 1.  Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment.

Authors:  D G Charteris
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638

2.  Naka-Rushton equation parameters in electroretinogram analysis of daunomycin effects on retinal function.

Authors:  D V Gangadhar; B M Wolf; H L Tanenbaum
Journal:  Doc Ophthalmol       Date:  1989-05       Impact factor: 2.379

3.  Toxicity of 1-(beta-D-arabinofuranosyl)cytosine after intravitreal injection in the rabbit eye.

Authors:  J J Diets-Ouwehand; R J de Keizer; G F Vrensen; S Groen-Jansen; J A van Best
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

4.  Effects of selected repeated intravitreal chemotherapeutic agents.

Authors:  J Vernot; G A Peyman; R Gailitis; R Fiscella; M Woodhouse; D Weinberg
Journal:  Int Ophthalmol       Date:  1985-11       Impact factor: 2.031

5.  Suppression of experimental proliferative vitreoretinopathy by sustained intraocular delivery of 5-FU.

Authors:  H Borhani; G A Peyman; M H Rahimy; H Thompson
Journal:  Int Ophthalmol       Date:  1995       Impact factor: 2.031

6.  Evaluation of toxicity and efficacy of a combination of antineoplastic agents in the prevention of PVR.

Authors:  M Salah-Eldin; G A Peyman; M el-Aswad; B Bandok; M M Bahgat; M R Niesman
Journal:  Int Ophthalmol       Date:  1994       Impact factor: 2.031

7.  Intravitreal Injections: A Historic Background.

Authors:  Gholam A Peyman
Journal:  J Ophthalmic Vis Res       Date:  2018 Apr-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.